// App-Quantinova.ai

2131 : Liver fibrosis as assessed by the FIB‐4 index and metabolic markers in subjects with type 2 Diabetes

Researchers

Presenter

  • Claudia M. Filozof

Principal Investigators

  • Stephen Jones

  • Margery A. Connelly

  • Marcia Eisenberg

  • Barry J. Goldstein

Medical Centers

  • LabCorp, North Carolina, NC

  • Covance, Inc., Princeton, NJ

  • CVM, Covance, Maidenhead, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Fatty Liver Disease

  • Hepatic fibrosis

  • Type 2 diabetes mellitus

  • Diabetes

  • Nonalcoholic fatty liver disease

Biomarkers

  • Alanine transaminase

  • Aspartate aminotransferase

  • Fibrosis-4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved